A PHASE 1/2A, MULTICENTER, FIRST-IN-HUMAN, OPEN-LABEL CLINICAL TRIAL EVALUATING MDX2001, A TETRASPECIFIC T CELL ENGAGER-EXPANDER IN PATIENTS WITH ADVANCED SOLID TUMOR (NCT06239194)